Status:
COMPLETED
An Approved Drug to Study a New Indication for Allergic Rhinitis (0476-327)
Lead Sponsor:
Organon and Co
Conditions:
Rhinitis, Allergic, Seasonal
Eligibility:
All Genders
15-64 years
Phase:
PHASE3
Brief Summary
The purpose of this trial is to evaluate the efficacy and safety of an investigational drug in adult patients with allergic rhinitis.
Eligibility Criteria
Inclusion
- Japanese males and females with a 2-year documented history of seasonal allergic rhinitis symptoms and positive allergy testing (cedar, alder and/or cypress)
Exclusion
- Patients with drug-induced rhinitis or non-allergic rhinitis, or patients who used anti-histamine drugs (within 2 weeks) before the start of the observation period
Key Trial Info
Start Date :
November 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2005
Estimated Enrollment :
1375 Patients enrolled
Trial Details
Trial ID
NCT00127647
Start Date
November 1 2004
End Date
April 1 2005
Last Update
August 15 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.